These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 2397001

  • 1. Onset of cardiovascular action after oral ibopamine. Early hemodynamic effects of single and repeated doses in patients with idiopathic dilated myocardiopathy.
    Di Mario C, Compostella L, Iavernaro A, Libardoni M, Ghirardi P, Cucchini F.
    Arzneimittelforschung; 1990 Jun; 40(6):661-6. PubMed ID: 2397001
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of ibopamine treatment in patients with advanced heart failure: purpose of a new therapeutic scheme with multiple daily administrations.
    Dei Cas L, Metra M, Nodari S, Visioli O.
    J Cardiovasc Pharmacol; 1989 Jun; 14 Suppl 8():S111-7. PubMed ID: 2483436
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the acute hemodynamic effects of ibopamine and dopamine in chronic congestive heart failure.
    Sannia L, Ibba GV, Castellaccio M, Dore L.
    Arzneimittelforschung; 1986 Feb; 36(2A):355-9. PubMed ID: 3707649
    [Abstract] [Full Text] [Related]

  • 4. Hemodynamic evaluation during exercise test after acute and chronic ibopamine treatment in patients with congestive heart failure.
    Gavazzi A, Mussini A, Bramucci E.
    Arzneimittelforschung; 1986 Feb; 36(2A):366-70. PubMed ID: 3707652
    [Abstract] [Full Text] [Related]

  • 5. The hemodynamic effects of ibopamine, a dopamine congener, in patients with congestive heart failure.
    Leier CV, Ren JH, Huss P, Unverferth DV.
    Pharmacotherapy; 1986 Feb; 6(1):35-40. PubMed ID: 3952005
    [Abstract] [Full Text] [Related]

  • 6. Invasive pharmacodynamic characterization of combined ibopamine and calcium blocker therapy for heart failure.
    Munger MA, Nara AR, Pospisil RA, Stoddard GJ, Schleman M.
    Pharmacotherapy; 1993 Feb; 13(3):218-23. PubMed ID: 8100627
    [Abstract] [Full Text] [Related]

  • 7. [Renal effects of ibopamine in comparison with furosemide in patients with mild heart failure].
    Wehling M, Zimmermann J, Weil J, Gerzer R, Theisen K.
    Z Kardiol; 1990 Feb; 79(2):120-5. PubMed ID: 2157313
    [Abstract] [Full Text] [Related]

  • 8. Effects of ibopamine on systemic, pulmonary and regional hemodynamics. Experimental investigations in anesthetized dogs.
    Merlo L, Ghirardi P, Brusoni B, Mussini E, Marchetti G.
    Arzneimittelforschung; 1986 Feb; 36(2A):304-11. PubMed ID: 3707641
    [Abstract] [Full Text] [Related]

  • 9. Acute effects of ibopamine hydrochloride on hemodynamics, plasma catecholamine levels, renin activity, aldosterone, metabolism and blood gas in patients with severe congestive heart failure.
    Nakano T, Morimoto Y, Kakuta Y, Konishi T, Kodera T, Kanamaru M, Takezawa H.
    Arzneimittelforschung; 1986 Dec; 36(12):1829-34. PubMed ID: 3551968
    [Abstract] [Full Text] [Related]

  • 10. Long-term therapy of chronic congestive heart failure with ibopamine: a multicenter trial.
    Rolandi E, Sabino F, Cantoni V, Ghirardi P, Marchetti GV, Cicchetti V.
    J Cardiovasc Pharmacol; 1989 Dec; 14 Suppl 8():S93-103. PubMed ID: 2483446
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of acute hemodynamic effects and pharmacokinetic behaviour of ibopamine in patients with severe heart failure.
    De Vita C, Triulzi E, Devizzi S, Colombo G, Palvarini M, Pocchiari F, Pataccini R.
    Arzneimittelforschung; 1986 Feb; 36(2A):349-54. PubMed ID: 3707648
    [Abstract] [Full Text] [Related]

  • 12. [Neurohumoral and hemodynamic effects in combination therapy of enoximone and dopamine].
    Mitrovic V, Neuzner J, Opper H, Thormann J, Schlepper M.
    Z Kardiol; 1994 Feb; 83 Suppl 2():37-48. PubMed ID: 8091823
    [Abstract] [Full Text] [Related]

  • 13. Hemodynamic evaluation of ibopamine in patients with refractory congestive heart failure.
    Humar F, Morgera T, Maras P, Camerini F.
    Arzneimittelforschung; 1986 Feb; 36(2A):360-2. PubMed ID: 3707650
    [Abstract] [Full Text] [Related]

  • 14. Acute hemodynamic effects of sildenafil in patients with idiopathic dilated cardiomyopathy.
    Ramakrishnan S, Malik V, Karthikeyan G, Seth S, Yadav R, Singh S, Deepak KK, Bhargava B.
    Indian Heart J; 2008 Feb; 60(6):599-601. PubMed ID: 19276506
    [Abstract] [Full Text] [Related]

  • 15. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.
    Givertz MM, Hare JM, Loh E, Gauthier DF, Colucci WS.
    J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566
    [Abstract] [Full Text] [Related]

  • 16. Hemodynamic response to ibopamine in acute myocardial infarction.
    Taniguchi H, Iwasaka T, Sugiura T, Takayama Y, Sumimoto T, Onoyama H, Takashima H, Nakamura S, Inada M.
    Arzneimittelforschung; 1990 Apr; 40(4):428-31. PubMed ID: 2357243
    [Abstract] [Full Text] [Related]

  • 17. Effects of ibopamine on peripheral hemodynamics: a strain gauge plethysmographic study in patients with congestive heart failure.
    Musacci GF, Ansani L, Toselli T, Aggio S, Baracca E, Longhini C.
    Arzneimittelforschung; 1986 Feb; 36(2A):380-2. PubMed ID: 3707654
    [Abstract] [Full Text] [Related]

  • 18. Influence of ibopamine on heart rate and arrhythmic pattern in patients with congestive heart failure. A double-blind multicentre study.
    G Ital Cardiol; 1989 Jan; 19(1):71-80. PubMed ID: 2663585
    [Abstract] [Full Text] [Related]

  • 19. The efficacy of ibopamine in long-term treatment of dilated cardiomyopathy. A clinical and instrumental evaluation.
    Benassi A, Modena MG, Mattioli G.
    Arzneimittelforschung; 1986 Feb; 36(2A):390-4. PubMed ID: 3518726
    [Abstract] [Full Text] [Related]

  • 20. Cardiovascular profile of UDCG 115 BS-pimobendane and reversibility of catecholamine subsensitivity in severe congestive heart failure secondary to idiopathic dilated cardiomyopathy.
    Baumann G, Ningel K, Permanetter B.
    J Cardiovasc Pharmacol; 1989 May; 13(5):730-8. PubMed ID: 2472521
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.